SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 30, 16:00
639.70
13.05 (2.08%)
VOLUME 143,842
LIVE
NSE
Sep 30, 15:59
639.70
12.85 (2.05%)
VOLUME 1,425,855
News on Ranbaxy Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Barring IT & pharma, Q2 earnings to disappoint: Dimensions 

10.21 am | 30 Sep 2014 |  Source: CNBC-TV18

The second quarter India Inc earnings, which will kick-off from the October 10 could be a disappointment barring IT and pharma companies, Ajay Srivast...

Super Six short term picks for September 30 

8.19 am | 30 Sep 2014 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com is of the view that one may sell ICICI Bank with a target of Rs 1400 and Jain Irrigation Systems with a target of Rs...

Does Sun Pharma have more steam after 8% rally in 2 days? 

5.00 pm | 29 Sep 2014 |  Source: CNBC-TV18

Sun Pharma may not really shoot up beyond Rs 880-900 immediately but then if you are looking at long term even at these levels you should buy the stoc...

Expert talk: Sun Pharma brilliant but not to be bought now 

3.49 pm | 29 Sep 2014 |  Source: CNBC-TV18

Investors have been lapping up pharma stocks in the recent few days and Sun Pharma has been one of the many beneficiaries. The stock has gained 46 per...

Buy Asian Paints, Titan, Ranbaxy: Vishal Malkan 

2.46 pm | 29 Sep 2014 |  Source: CNBC-TV18

Vishal Malkan of malkansview.com recommends buying Asian Paints, Titan Company and Ranbaxy Laboratories....

Ranbaxy Laboratories' Q2 results on October 28, 2014

1.49 pm | 29 Sep 2014 |  Source: Moneycontrol.com

Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 28, 2014, inter alia, to con...

Sun Pharma to focus on dermatology post merger with Ranbaxy 

12.51 pm | 29 Sep 2014 |  Source: CNBC-TV18

The company has lined-up a strategy to make dermatology its biggest segment and expects almost 38-40 percent of US sales to come from dermatology by F...

USFDA bans two Indian plants on GMP violations

9.28 pm | 26 Sep 2014 |  Source: CNBC-TV18

The USFDA has served import alerts to Canadian drug company Apotex Research’s manufacturing facility in Bangalore and Indian firm Micro Labs manufac...

Forbes India rich list: Mukesh Ambani tops, Adani moves up

8.54 am | 25 Sep 2014 |  Source: Moneycontrol.com

Mukesh Ambani tops the list for the eighth consecutive year with a net worth of USD 23.6 billion, followed by Dilip Shanghvi of Sun Pharma. However, t...

Sun-Ranbaxy deal: CCI public scrutiny deadline ends today

6.40 pm | 24 Sep 2014 |  Source: PTI

This is also the first M&A deal where the Competition Commission of India (CCI) has ordered a public scrutiny of after forming a "prima facie opinion ...

Ranbaxy Laboratories: Outcome of court convened meeting of equity shareholders

1.49 pm | 24 Sep 2014 |  Source: Moneycontrol.com

Ranbaxy Laboratories Ltd has informed BSE regarding ...

Hold Sun Pharma; may test Rs 855-860: Akshata Deshmukh 

3.02 pm | 19 Sep 2014 |  Source: CNBC-TV18

Akshata Deshmukh of Networth Stock Broking is of the view that one may hold Sun Pharmaceutical Industries....

Stocks in news: Tata Motors, GTL Infra, ICICI, Cipla, SPML

8.22 am | 19 Sep 2014 |  Source: CNBC-TV18

Tata Motors | Tata Chemicals | Tata Steel | Tata Power | Tech Mahindra | Bosch | GTL Infrastructure | SBI | Axis Bank | ICICI Bank | Manappuram Financ...

NPPA reviews drugs under price control list; rejigs some 

5.55 pm | 18 Sep 2014 |  Source: CNBC-TV18

The national pharmaceutical pricing authority (NPPA) has widened its ambit by adding new strengths of 43 drugs under price control, out of which major...

Buy Crompton, Ranbaxy; sell Rel Cap: Meghana Malkan 

1.37 pm | 18 Sep 2014 |  Source: CNBC-TV18

Meghana Malkan of malkansview.com is of the view that one may buy Ranbaxy Laboratories for a target price of Rs 615 and sell Reliance Capital for a ta...

Here are top 10 stocks to watch on Sep 18 

8.46 am | 18 Sep 2014 |  Source: CNBC-TV18

Here are top 10 stocks to watch on Sep 18 - GMR Infra, Reliance Industries, Sun Pharma, Ranbaxy, Texrail, ITC, MCX, Yes Bank, Rel Comm and Aegis Logis...

Bull's Eye: Buy Siemens, Crompton, NBCC, Ranbaxy, Biocon 

8.46 am | 18 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan, malkansview.com advises buying Crompton Greaves for a target price of Rs 221 and Century Textiles for a target price of Rs 595....

Stocks in news: Sun Pharma, Ranbaxy, YES Bank, Apollo Tyres

8.24 am | 18 Sep 2014 |  Source: CNBC-TV18

Sun Pharma | Ranbaxy Labs | NCC | SPML Infra | Chambal Fertilizers | YES Bank | GTL Infrastructure | Apollo Tyres | Samruddhi Realty | Mirc Electronic...

Super Six buy or sell calls for September 18

8.24 am | 18 Sep 2014 |  Source: CNBC-TV18

Vishal Malkan of malkansview.com advises buying Ranbaxy Laboratories with a target of Rs 620-630 and Crompton Greaves with a target of Rs 222-226....

Ranbaxy receives CID from US Justice Department 

7.30 pm | 17 Sep 2014 |  Source: CNBC-TV18

A civil investigative demand in this case means that the US department of justice is reviewing the documents and information regarding how Ranbaxy pri...

1 2 3 4 5 6 7
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.